🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Batefenterol is a novel bifunctional molecule that combines muscarinic anta...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-11-06
Trial ID
NCT02570165
Treatments Being Tested
GSK961081 has previously been administered to healthy subjects in a nebulis...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06
Trial ID
NCT00478738
Treatments Being Tested
Salt Bridging study for GSK961081...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-29
Trial ID
NCT00550225
Treatments Being Tested
Batefenterol (BAT) is a novel bifunctional molecule that combines muscarini...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-01-27
Trial ID
NCT02666287
Treatments Being Tested
In the current study GSK961081 and fluticasone propionate will be administe...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-07-13
Trial ID
NCT01449799
GSK961081 is a new long-acting bronchodilator being developed for the treat...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-11-07
Trial ID
NCT00887406
Batefenterol (GSK961081) is a bifunctional bronchodilator that is being dev...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-02-08
Trial ID
NCT02663089
Study will investigate the pharmacodynamics of a dual pharmacophore in whic...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-03-10
Trial ID
NCT00687700
Treatments Being Tested
GSK961081 is a novel bifunctional molecule that combines muscarinic antagon...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-02-19
Trial ID
NCT02064504
Treatments Being Tested
Batefenterol inhalation powder is currently under development as a fixed-do...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-12-01
Trial ID
NCT02573870
Treatments Being Tested